Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Bicycle Therapeutics Plc ADR (BCYC)

Bicycle Therapeutics Plc ADR (BCYC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Bicycle Therapeutics Plc ADR BLOCKS A & B PORTWAY BUILDING GRANTA PARK GREAT ABINGTON CAMBRIDGE X0 CB21 6GS GBR

www.bicycletherapeutics.com P: 44-12-2326-1503

Description:

Bicycle Therapeutics plc is a clinical-stage biopharmaceutical company. It is focused on developing medicines, referred to as Bicycles(R) for diseases which are underserved by existing therapeutics. Bicycle Therapeutics plc is based in Cambridge, United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 1,039,529
Enterprise Value, $K 543,809
Shares Outstanding, K 42,779
Annual Sales, $ 26,980 K
Annual Net Income, $ -180,660 K
Last Quarter Sales, $ 19,530 K
Last Quarter Net Income, $ -26,560 K
EBIT, $ -179,870 K
EBITDA, $ -173,320 K
60-Month Beta 0.88
% of Insider Shareholders 8.50%
% of Institutional Shareholders 86.15%
Float, K 39,143
% Float 91.50%
Short Volume Ratio 0.44

Growth:

1-Year Return -13.45%
3-Year Return -19.65%
5-Year Return 98.45%
5-Year Revenue Growth 277.87%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.62 on 05/02/24
Next Earnings Date 08/01/24
Earnings Per Share ttm -4.45
EPS Growth vs. Prev Qtr 46.55%
EPS Growth vs. Prev Year 52.31%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

BCYC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -49.35%
Return-on-Assets % -30.09%
Profit Margin % -669.61%
Debt/Equity 0.09
Price/Sales 38.80
Price/Cash Flow N/A
Price/Book 2.94
Book Value/Share 8.32
Interest Coverage -53.97
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar